Cite

APA Citation

    Chi, X., Yu, Z., & Lin, R. (2022). bOB: Bayesian optimal design for biosimilar trials with co‐primary endpoints. Statistics in medicine, 41, 5319–5334. http://access.bl.uk/ark:/81055/vdc_100168595022.0x000045
  
Back to record